Did you mean 2,3 50 4?
Displaying drugs 8126 - 8150 of 11017 in total
CTT-1057
CTT-1057 is under investigation in clinical trial NCT03427476 (CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma).
Investigational
Matched Iupac: … (2S)-2-({[(4S)-4-carboxy-4-[(4S)-4-carboxy-4-{6-[(4-fluorophenyl)formamido]hexanamido}butanamido]butoxy …
Golvatinib
Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
Investigational
Matched Iupac: … N'1-{2-fluoro-4-[(2-{[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino}pyridin-4-yl)oxy]phenyl}- ... N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide …
Matched Categories: … Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors …
Matched Categories: … Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors …
Landiolol
Landiolol is a rapid-acting beta-blocker used for rapid ventricular rate control.
Investigational
Matched Iupac: … [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-{4-[(2S)-2-hydroxy-3-({2-[(morpholine-4-carbonyl)amino] …
Retagliptin
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
Investigational
Matched Iupac: … methyl 7-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(trifluoromethyl)-5H,6H,7H,8H-imidazo[1,5 …
Matched Description: … NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 …
Matched Description: … NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 …
2-Oxobutanoic Acid
Experimental
Matched Name: … 2-Oxobutanoic Acid …
Matched Iupac: … 2-oxobutanoic acid …
Matched Iupac: … 2-oxobutanoic acid …
LY2140023
LY2140023 is an investigational drug from Lilly, which is being developed as a new treatment option for schizophrenia. LY2140023 is an oral "prodrug," meaning it is devoid of intrinsic biological activity and, once administered, is metabolized to provide the active mGlu2/3 receptor agonist called LY404039. Most currently approved antipsychotic medications...
Investigational
2-Bromoacetyl Group
Experimental
Matched Name: … 2-Bromoacetyl Group …
Matched Iupac: … 2-bromoacetic acid …
Matched Iupac: … 2-bromoacetic acid …
2-(Sec-Butyl)Thiazole
Experimental
Matched Name: … 2-(Sec-Butyl)Thiazole …
Matched Iupac: … 2-[(2R)-butan-2-yl]-1,3-thiazole …
Matched Iupac: … 2-[(2R)-butan-2-yl]-1,3-thiazole …
2-Iminiopropanoate
Experimental
Matched Name: … 2-Iminiopropanoate …
Matched Iupac: … 2-iminiumylpropanoate …
Matched Iupac: … 2-iminiumylpropanoate …
1-Methyl-2-quinolone
Experimental
Matched Name: … 1-Methyl-2-quinolone …
Matched Iupac: … 1-methyl-1,2-dihydroquinolin-2-one …
Matched Iupac: … 1-methyl-1,2-dihydroquinolin-2-one …
1,2-dichlorobenzene
1,2-Dichlorobenzene, also named ortho-dichlorobenzene, is an organic compound. It is a non-polar colorless liquid that is miscible in most organic solvents. This derivative of benzene differs from the parent compound by the presence of two adjacent chlorine atoms. 1,2-dichlorobenzene is used as a precursor for agrochemicals, as a solvent for...
Experimental
Matched Synonyms: … 2-Dichlorobenzene …
Carbon black
Produced by the incomplete combustion of hydrocarbons, carbon black is an insoluble pigment with demonstrated adverse effects on pulmonary function. Upon inhalation, carbon black has been reported to trigger an inflammatory response in the lung tissue and has been linked to carcinogenicity.[A263406, A263411, A263416]
Investigational
Matched Synonyms: … BLACK 2 ... D&C black no. 2 ... DC BLACK NO. 2 …
5'-O-[(L-methionyl)-sulphamoyl]adenosine
Experimental
Matched Name: … 5'-O-[(L-methionyl)-sulphamoyl]adenosine …
Matched Iupac: … (2S)-2-amino-1-[({[(2R,3S,4R,5R)-5-(6-amino-4,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy ... }sulfonyl)amino]-2-[2-(methylsulfanyl)ethyl]ethan-1-one …
Matched Iupac: … (2S)-2-amino-1-[({[(2R,3S,4R,5R)-5-(6-amino-4,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy ... }sulfonyl)amino]-2-[2-(methylsulfanyl)ethyl]ethan-1-one …
N-Pyridoxyl-Glycine-5-Monophosphate
Experimental
Matched Name: … N-Pyridoxyl-Glycine-5-Monophosphate …
Matched Iupac: … 2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]acetic acid …
Matched Iupac: … 2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]acetic acid …
5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine
Experimental
N-acetyl-alpha-D-glucosamine
The N-acetyl derivative of glucosamine.
Experimental
Matched Synonyms: … 2-(acetylamino)-2-deoxy-A-D-glucopyranose ... 2-(acetylamino)-2-deoxy-α-D-glucopyranose …
Denenicokin
Denenicokin is under investigation in clinical trial NCT01152788 (Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma).
Investigational
N-T-Butylhydroxylamine
Investigational
Matched Synonyms: … 2-hydroxylamino-2-methylpropane ... N-hydroxy-2-methyl-2-propanamine …
Darleukin
Investigational
N-(2-Aminoethyl)-1-aziridineethanamine
First described in the literature in 2004, N-(2-Aminoethyl)-1-aziridineethanamine is an experimental angiotensin converting enzyme 2 inhibitor investigated for its use in treating cardiovascular disease and its activity against Severe Acute Respiratory Syndrome (SARS).
Experimental
Matched Synonyms: … N-(2-((2-Aminoethyl)amino)ethyl)aziridine ... N-(2-aminoethyl)-1 aziridine-ethanamine …
Matched Name: … N-(2-Aminoethyl)-1-aziridineethanamine …
Matched Iupac: … (2-aminoethyl)[2-(aziridin-1-yl)ethyl]amine …
Matched Description: … First described in the literature in 2004, N-(2-Aminoethyl)-1-aziridineethanamine is an experimental ... angiotensin converting enzyme 2 inhibitor investigated for its use in treating cardiovascular disease …
Matched Name: … N-(2-Aminoethyl)-1-aziridineethanamine …
Matched Iupac: … (2-aminoethyl)[2-(aziridin-1-yl)ethyl]amine …
Matched Description: … First described in the literature in 2004, N-(2-Aminoethyl)-1-aziridineethanamine is an experimental ... angiotensin converting enzyme 2 inhibitor investigated for its use in treating cardiovascular disease …
6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE
Experimental
Matched Name: … 6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE …
Matched Iupac: … 6-(2-{3'-methoxy-[1,1'-biphenyl]-3-yl}ethyl)pyridin-2-amine …
Matched Iupac: … 6-(2-{3'-methoxy-[1,1'-biphenyl]-3-yl}ethyl)pyridin-2-amine …
Lirentelimab
Lirentelimab is under investigation in clinical trial NCT04856891 (A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis).
Investigational
Matched Synonyms: … IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SIALIC ACID-BINDING IG-LIKE LECTIN 8 (SIALOADHESIN FAMILY MEMBER 2, ... SIGLEC-8, SAF-2))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV3 …
Eflepedocokin alfa
Eflepedocokin alfa is a recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 human interleukin 22 (IL-22) molecules linked to an immunoglobulin constant region (IgG2-Fc).[A225706, L27661] It is being developed by Evive Biotech (previously known as Generon BioMed Inc).
Investigational
Matched Description: … recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 …
Displaying drugs 8126 - 8150 of 11017 in total